Organon & Co
988 hedge funds and large institutions have $5.23B invested in Organon & Co in 2021 Q2 according to their latest regulatory filings, with 988 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
68.81% more ownership
Funds ownership: 0% → 68.81% (+69%)
7% less call options, than puts
Call options by funds: $13M | Put options by funds: $13.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$952M |
| 2 |
BlackRock
New York
|
+$543M |
| 3 |
State Street
Boston,
Massachusetts
|
+$279M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$190M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$167M |
Top Sellers
OGN Hedge Fund Activity: Q2 2021 in Review
988 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q2 2021, worth a combined $5.23B.
Buyers outnumbered sellers: 988 funds opened new OGN positions and 0 closed out — a net gain of 988 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $952M.
- 988 institutional investors held Organon & Co (OGN) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $5.23B of Organon & Co stock for Q2 2021.
- 988 funds opened new Organon & Co positions in Q2 2021 and 0 closed out, a net change of +988 holders.
- The largest Organon & Co buyer in Q2 2021 was Vanguard Group, an estimated $952M added.
Based on aggregated 13F filings for Q2 2021.